Link to this page
Medical Subject Headings
Last uploaded:
August 28, 2024
Jump to:
| Preferred Name | rotigotine | |
| Synonyms |
N-0437 rotigotine, (+)- 1-naphthalenol, 5,6,7,8-tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)- rotigotine (+-)-form Rotigotine CDS N 0437, hydrochloride, (R)-isomer N 0437 rotigotine, (+--)- N 0437, (R)-isomer N-0923 Neupro N 0924 (+)-5,6,7,8-tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-1-naphthol (+--)-5,6,7,8-tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-1-naphthol 2-(N-n-propyl-N-2-thienylethylamino)-5-hydroxytetralin N 0923 N 0437, (-)-isomer N 0437, hydrochloride, (S)-isomer N-0924 racemic N-0437 N 0437, (+-)-isomer |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C047508 |
|
| altLabel |
N-0437 rotigotine, (+)- 1-naphthalenol, 5,6,7,8-tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)- rotigotine (+-)-form Rotigotine CDS N 0437, hydrochloride, (R)-isomer N 0437 rotigotine, (+--)- N 0437, (R)-isomer N-0923 Neupro N 0924 (+)-5,6,7,8-tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-1-naphthol (+--)-5,6,7,8-tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-1-naphthol 2-(N-n-propyl-N-2-thienylethylamino)-5-hydroxytetralin N 0923 N 0437, (-)-isomer N 0437, hydrochloride, (S)-isomer N-0924 racemic N-0437 N 0437, (+-)-isomer
|
|
| cui |
C0129569 C4318637 C1700683 C1949346 C0956956 C1101411 C0956959 C0956960 C0067092 C0956957 C0956958 C0092275 C0129570
|
|
| HM |
D013764 D013876
|
|
| Inverse of RB |
99755-59-6 125572-92-1 N8FO6Z42IR 125572-93-2 5QTR54Z0E1 0 113349-24-9 112835-48-0 87T4T8BO2E
|
|
| isa | ||
| LT |
TRD
|
|
| Mapped to | ||
| MDA |
19860116
|
|
| MeSH Frequency |
421
|
|
| MMR |
20170616
|
|
| notation |
C047508
|
|
| PA |
D018491
|
|
| prefLabel |
rotigotine
|
|
| RR |
99755-59-6 (N 0437, (-)-isomer) 125572-93-2 (N 0437, hydrochloride, (S)-isomer) N8FO6Z42IR 113349-24-9 (N 0437, (+-)-isomer) 5QTR54Z0E1 125572-92-1 (N 0437, hydrochloride, (R)-isomer) 112835-48-0 (N 0437, hydrochloride, (R)-isomer)
|
|
| SC |
1
|
|
| Scope Statement |
Antiparkinson Agent and dopamine receptor agonist; structure given in first source; RN given refers to cpd without isomeric designation
|
|
| SRC |
Pharm Weekbl Sci 1985;7(5):208
|
|
| TERMUI |
T352605 T693603 T000927145 T167183 T813666 T000927143 T000927146 T464001 T000909708 T000909706 T167180 T000909707 T352604 T352608 T167181 T000927144 T167179 T167184 T167185 T167182 T352607 T352606
|
|
| TH |
FDA SRS (2017) NLM (2012) NLM (2001) USAN (19XX) INN (19XX) NLM (1986) NLM (2006) NLM (2017)
|
|
| tui |
T109 T121
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping